Showing 941 - 960 results of 24,876 for search '(( e point decrease ) OR ( 100 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 0.97s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    “…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. …”
  5. 945
  6. 946
  7. 947

    Phospho-ERK level is decreased in 3D spheroids. by Keven Huang (675616)

    Published 2014
    “…(<b>C</b>) At 100,000 cells per spheroid, HeyA8 cells treated with SDF-1α and PMA showed activation of phospho-ERK levels. (**, P <0.005 vs Adh, 1-way ANOVA). …”
  8. 948
  9. 949

    IgG binds to GluN2B and decreases CaMKII binding to GluN2B. by Dayton J. Goodell (559732)

    Published 2014
    “…Bar graphs indicate mean ± s.e.m, and GST-GluN2B detection is shown as a loading control. …”
  10. 950
  11. 951
  12. 952
  13. 953
  14. 954
  15. 955

    Inhibition of HDAC6 activity decreased the phosphorylation of ERK1/2 and normalized the localization of EGFR from apical to basolateral. by Wei Liu (20030)

    Published 2013
    “…<p>(A) Knockdown HDAC6 with shRNA increases the degradation of EGFR and decreases the phosphorylation of ERK1/2. …”
  16. 956

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
  17. 957
  18. 958
  19. 959
  20. 960

    Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges. by Jaclyn M. Kline (9565161)

    Published 2020
    “…(B) Tactile sensitivity in sensitized mice preventatively treated with imatinib or NT and then 10 daily MI challenges. Results reported as mean ± SEM of the percent decrease from baseline in the withdrawal threshold for each treatment group, n = 18/treatment group. …”